 BEIJING and BOSTON, Dec. 23, 2020 GLOBE NEWSWIRE -- 1Globe Capital LLC 1GlobeCap, a principal and long-term shareholder of Sinovac Biotech NASDAQ: SVA Sinovac, has reached agreement with the Securities and Exchange Commission SEC to end investigation of its 13D form compliance. 